Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Treatment of ADHD with stimulant medications: response to Nissen perspective in the New England Journal of Medicine.

Biederman J, Spencer TJ, Wilens TE, Prince JB, Faraone SV.

J Am Acad Child Adolesc Psychiatry. 2006 Oct;45(10):1147-50. No abstract available.

PMID:
16840880
2.
3.

Cardiovascular safety of ADHD medication treatments.

Newcorn JH.

CNS Spectr. 2008 Oct;13(10 Suppl 15):5-8. No abstract available.

PMID:
18955948
4.

Stimulants and sudden death: what is a physician to do?

Wilens TE, Prince JB, Spencer TJ, Biederman J.

Pediatrics. 2006 Sep;118(3):1215-9. Review.

PMID:
16951018
5.

[Medication for ADHD and the risk of cardiovascular mortality].

Kalverdijk LJ, Buitelaar JK, van der Gaag RJ.

Ned Tijdschr Geneeskd. 2006 Oct 14;150(41):2283-4; author reply 2284. Dutch. No abstract available.

PMID:
17078147
6.

Medications for attention deficit hyperactivity disorder: cardiovascular concerns.

Wooltorton E.

CMAJ. 2006 Jul 4;175(1):29. Epub 2006 Jun 13. No abstract available.

7.

ECGs before stimulants in children.

[No authors listed]

Med Lett Drugs Ther. 2008 Jul 28;50(1291):60. No abstract available.

PMID:
18654112
8.

ADHD update: new data on the risks of medication.

[No authors listed]

Harv Ment Health Lett. 2006 Oct;23(4):3-5. No abstract available.

PMID:
17183739
9.

Long-term safety of stimulant medications used to treat children with ADHD.

Lerner M, Wigal T.

Pediatr Ann. 2008 Jan;37(1):37-45. Review. No abstract available.

PMID:
18240852
10.

Management of stimulant medications in children with attention-deficit/hyperactivity disorder.

Adesman AR, Morgan AM.

Pediatr Clin North Am. 1999 Oct;46(5):945-63, vii-viii. Review.

PMID:
10570698
11.

Stimulant therapy in attention deficit/hyperactivity disorder.

Baldwin RL.

J Ark Med Soc. 2003 Dec;100(6):203-6. Review.

PMID:
14661403
12.

Pharmacotherapy in ADHD. Guidelines for prescribing stimulant medications in young children.

August GJ, Realmuto GM.

Minn Med. 2000 Jun;83(6):45-6. No abstract available.

PMID:
10881573
13.

Dexmethylphenidate for attention deficit hyperactivity disorder.

Coury D.

Expert Opin Pharmacother. 2009 Nov;10(16):2679-85. doi: 10.1517/14656560903386284.

PMID:
19874250
14.

Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder.

Winterstein AG, Gerhard T, Shuster J, Johnson M, Zito JM, Saidi A.

Pediatrics. 2007 Dec;120(6):e1494-501.

PMID:
18055666
15.

Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.

Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S, Kroeger K.

J Am Acad Child Adolesc Psychiatry. 2001 Nov;40(11):1352-5.

PMID:
11699811
16.

Side effects of stimulant use.

Levy F.

J Paediatr Child Health. 1993 Aug;29(4):250-4. Review.

PMID:
8104015
17.

Stimulant medications.

Greenhill LL, Halperin JM, Abikoff H.

J Am Acad Child Adolesc Psychiatry. 1999 May;38(5):503-12. Review.

PMID:
10230181
19.

An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.

Chavez B, Sopko MA Jr, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT.

Ann Pharmacother. 2009 Jun;43(6):1084-95. doi: 10.1345/aph.1L523. Epub 2009 May 26. Review.

PMID:
19470858
20.

Stimulant treatment for ADHD may not increase risk of substance abuse.

[No authors listed]

Harv Ment Health Lett. 2008 Jun;24(12):7. No abstract available.

PMID:
18946888
Items per page

Supplemental Content

Write to the Help Desk